首站-论文投稿智能助手
典型文献
Global prevalence, mortality, and main risk factors for COVID-19 associated pneumocystosis: A systematic review and meta-analysis
文献摘要:
Objective: Pneumocystis pneumonia (PcP) is a life-threatening infection caused by the opportunistic fungi Pneumocystis jirovecii. The emergence of the COVID-19 pandemic forced the focus of attention of health policymakers on these two infections due to their clinical and paraclinical similarities, which cause diagnostic dilemmas. This study was undertaken to evaluate and estimate the global prevalence and main leading risk factors of coronavirus-associated pneumocystosis (CAP). Methods: We searched related databases between December 2019 and May 2022 for studies reporting CAP. Meta-analysis was performed using StatsDirect software (version 2.7.9) according to the DerSimonian and Laird method applying the random-effects model. We evaluated heterogeneity using the χ2-based Q statistic (significant for P<0.05) and the I2 statistic (>75% indicative of "notable" heterogeneity). Moreover, an odds ratio (OR) analysis was performed for eligible data. Results: Our meta-analysis included eight studies with 923 patients hospitalized with COVID-19; among them, 92 were PcP cases. The overall pooled prevalence of CAP was estimated at 11.5%. The mortality among CAP patients was lower than that of non-PcP patients (OR 1.93; 95% CI 0.86-4.31). Long-term corticosteroid therapy (OR 28.22; 95% CI 0.54-1480.84) was the most predisposing factor for PcP among COVID-19 patients, followed by pulmonary diseases (OR 1.46; 95% CI 0.43-4.98), kidney diseases (OR 1.26; 95% CI 0.21-7.49), and acute respiratory destruction syndrome (OR 1.22; 95% CI 0.05-29.28). Conclusions: The prevalence of PcP among the COVID-19 population is almost similar to the pre-COVID era. However, PcP-related mortality was decreased by the emergence of the COVID-19 pandemic. Women with COVID-19 are more susceptible to PcP than men. Acute respiratory distress syndrome, kidney diseases, pulmonary diseases, and long-term corticosteroid therapy increased the risk of PcP; however, transplantation and malignancy decreased the risk for PcP among COVID-19 patients. Further retrospective, case-control, prospective, and more precisely systematic review and meta-analysis studies are needed in this field.
文献关键词:
作者姓名:
Hossein Khodadadi;Ehsan Ahmadpour;Sanam Nami;Rasoul Mohammadi;Hanieh Hosseini;Mahsa Behravan;Hamid Morovati
作者机构:
Department of Parasitology and Mycology,School of Medicine,Shiraz University of Medical Sciences,Shiraz,Iran;Drug Applied Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Mycology and Parasitology,School of Medicine,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Parasitology and Mycology,School of Medicine,Isfahan University of Medical Sciences,Isfahan,Iran;Immunology Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Student Research Committee,Shiraz University of Medical Sciences,Shiraz,Iran
引用格式:
[1]Hossein Khodadadi;Ehsan Ahmadpour;Sanam Nami;Rasoul Mohammadi;Hanieh Hosseini;Mahsa Behravan;Hamid Morovati-.Global prevalence, mortality, and main risk factors for COVID-19 associated pneumocystosis: A systematic review and meta-analysis)[J].亚太热带医药杂志(英文版),2022(10):431-441
A类:
pneumocystosis,paraclinical,StatsDirect
B类:
Global,prevalence,mortality,main,risk,factors,associated,systematic,review,meta,analysis,Objective,Pneumocystis,pneumonia,PcP,life,threatening,caused,by,opportunistic,fungi,jirovecii,emergence,pandemic,forced,focus,attention,health,policymakers,these,two,infections,due,their,similarities,which,diagnostic,dilemmas,This,study,was,undertaken,global,leading,coronavirus,CAP,Methods,We,searched,related,databases,between,December,May,studies,reporting,performed,using,software,version,according,DerSimonian,Laird,method,applying,random,effects,model,evaluated,heterogeneity,statistic,significant,I2,indicative,notable,Moreover,odds,ratio,eligible,Results,Our,included,eight,patients,hospitalized,among,them,were,cases,overall,pooled,estimated,lower,than,that,Long,term,corticosteroid,therapy,predisposing,followed,pulmonary,diseases,kidney,acute,respiratory,destruction,syndrome,Conclusions,population,almost,However,decreased,Women,more,susceptible,Acute,distress,long,increased,however,transplantation,malignancy,Further,retrospective,control,prospective,precisely,needed,this,field
AB值:
0.498132
相似文献
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID?19 in a Han Chinese population from Central China
Yi Wu;Xian‑Hui Wang;Xi‑Hua Li;Li‑Yuan Song;Shi‑Long Yu;Zhi‑Cheng Fang;Yu‑Quan Liu;Le‑Yong Yuan;Chun‑Yan Peng;Shen‑Yi Zhang;Wang Cheng;Hong‑Chao Ma;Li‑Feng Wang;Jun‑Ming Tang;Yun‑Fu Wang;Fu‑Yun Ji-Department of Medical Biology,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Biomedical Research,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Human Respiratory Disease,Xinqiao Hospital,The Army Medical University(Third Military Medical University),400037 Chongqing,China;Department of Emergency Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Geriatric Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Immunology,School of Basic Medical Sciences,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Laboratory Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Hubei Key Laboratory of Embryonic Stem Cell Research,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Neurology,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
Can acupuncture enhance therapeutic effectiveness of antidepressants and reduce adverse drug reactions in patients with depression?A systematic review and meta-analysis
Ming-min Xu;Pei Guo;Qing-yu Ma;Xuan Zhou;Yu-long Wei;Lu Wang;Yue Chen;Yu Guo-School of Traditional Chinese Medicine,Jinan University,Guangzhou 510632,Guangdong Province,China;Acupuncture and Tuina School/Third Teaching Hospital,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,Sichuan Province,China;School of Medicine,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,Sichuan Province,China;Guangzhou Key Laboratory of Formula-Pattern of Traditional Chinese Medicine,Formula-Pattern Research Center,Jinan University,Guangzhou 510632,Guangdong Province,China;School of Acupuncture-Moxibustion and Tuina,Beijing University of Chinese Medicine,Beijing 100029,China
Multimorbidity patterns and association with mortality in 0.5 million Chinese adults
Fan Junning;Sun Zhijia;Yu Canqing;Guo Yu;Pei Pei;Yang Ling;Chen Yiping;Du Huaidong;Sun Dianjianyi;Pang Yuanjie;Zhang Jun;Gilbert Simon;Avery Daniel;Chen Junshi;Chen Zhengming;Lyu Jun;Li Liming-Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China;Peking University Center for Public Health and Epidemic Preparedness and Response, Peking University, Beijing 100191, China;National Clinical Research Center of Cardiovascular Diseases, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;China Kadoorie Biobank National Coordination Centre, Chinese Academy of Medical Sciences, Beijing 100730, China;Nuffield Department of Population Health, Medical Research Council Population Health Research Unit, University of Oxford, Oxford OX3 7LF, United Kingdom;Nuffield Department of Population Health, University of Oxford, Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Oxford OX3 7LF, United Kingdom;Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu 215004, China;China National Center for Food Safety Risk Assessment, Beijing 100022, China;Key Laboratory of Molecular Cardiovascular Sciences, Peking University, Ministry of Education, Beijing 100191, China
Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis
Liu Jiaye;Tian Ye;Fu Xia;Mu Chunyang;Yao Menglin;Ni Yinyun;Liu Yong;Li Zhihui-Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Laboratory of Thyroid and Parathyroid Diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610000, China;Respiratory Health Institute, Frontiers Science Center for Disease Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Ultrasound, West China Hospital of Sichuan University, Chengdu, Sichuan 610000, China;Department of Outpatients, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Gastroenterological Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China
Prevalence and risk factors of enteral nutrition intolerance in intensive care unit patients: a retrospective study
Yu Kunrong;Guo Na;Zhang Dingding;Xia Ying;Meng Yanling;Weng Li;Du Bin-Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China;Department of Nursing, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China;Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;Department of Medical Intensive Care Unit, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。